CIK 0001339970
- Non-accelerated filer
- Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203435077
- Phone
- +1 858-731-8389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- 4 Open-market buy CEO and Director bought 124 shares at $3.00 ($372)
- 4 Open-market buy CEO and Director bought 2,552 shares at $3.00 ($7,656)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 25,000 shares at an average $2.28 ($56,928)
- 4 Open-market buy Vice President, Manufacturing bought 11,000 shares at $2.25 ($24,749)
- 4 Open-market buy CEO and Director bought 69,000 shares at $2.20 ($151,662)
- 4 Open-market buy Director bought 50,000 shares at an average $2.48 ($123,885)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 10 of 17 · 329 filings